Markets:

Overview

News

Currencies

International

Treasuries

Solventum Corporation Common Stock (NY:SOLV)

82.90 +3.39 (+4.26%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Solventum (SOLV) Stock Is Up Today

September 08, 2025

Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 2.3% in the afternoon session after the company announced the early results of its tender offers for outstanding notes and increased...

Via StockStory

Topics Government World Trade

Discover which S&P500 stocks are making waves on Monday. ↗

September 08, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

3 Low-Volatility Stocks We Keep Off Our Radar

August 26, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Surgical Equipment & Consumables - Diversified Stocks Q2 Teardown: Solventum (NYSE:SOLV) Vs The Rest

August 20, 2025

Let’s dig into the relative performance of Solventum (NYSE:SOLV) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season.

Via StockStory

Topics Artificial Intelligence Economy

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

MediWound Revenue Jumps 43% in Q2 ↗

August 14, 2025

Via The Motley Fool

Which S&P500 stocks have an unusual volume on Thursday? ↗

August 14, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Thursday's session.

Via Chartmill

SOLV Q2 Deep Dive: Product Launches and Execution Drive Outperformance Amid Margin Pressures

August 12, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per...

Via StockStory

Topics World Trade

Which S&P500 stocks are moving on Monday? ↗

August 11, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

3 Mid-Cap Stocks We Keep Off Our Radar

August 11, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Forecasting The Future: 3 Analyst Projections For Solventum ↗

August 08, 2025

Via Benzinga

Solventum (SOLV) Q2 2025 Earnings Call Transcript ↗

August 07, 2025

Via The Motley Fool

Topics Earnings World Trade

Solventum (SOLV) Fiscal Q2 EPS Jumps 8% ↗

August 07, 2025

Via The Motley Fool

Topics Economy World Trade

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

August 07, 2025

Wondering what's happening in today's after-hours session with S&P500 stocks? Stay tuned for the latest updates on movers and shakers.

Via Chartmill

Solventum Corp (NYSE:SOLV) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Slight Revenue Miss ↗

August 07, 2025

Solventum Corp (NYSE:SOLV) reported mixed Q2 2025 earnings, beating EPS estimates at $1.69 but slightly missing revenue forecasts. Shares rose 3% post-announcement.

Via Chartmill

Solventum’s (NYSE:SOLV) Q2: Beats On Revenue

August 07, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was...

Via StockStory

Solventum (SOLV) Reports Earnings Tomorrow: What To Expect

August 05, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) will be announcing earnings results this Thursday afternoon. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence World Trade

ZimVie Doubles — And Then Some — On Its Second Takeover Deal ↗

July 21, 2025

The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed.

Via Investor's Business Daily

3 Cash-Producing Stocks with Questionable Fundamentals

July 18, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned...

Via StockStory

Topics ETFs Stocks World Trade

1 Value Stock for Long-Term Investors and 2 to Approach with Caution

July 11, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

3 Mid-Cap Stocks with Questionable Fundamentals

June 20, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

3 Low-Volatility Stocks Facing Headwinds

June 17, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

SOLVENTUM CORP (NYSE:SOLV) - A Strong Technical Setup for Breakout Investors ↗

June 14, 2025

SOLVENTUM CORP (NYSE:SOLV) shows strong technicals and a high-quality setup, making it a breakout candidate for traders. The stock has outperformed 83% of the market and presents clear support levels.

Via Chartmill

SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum

June 10, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of...

Via StockStory

Topics Economy World Trade

Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & Consumables - Diversified Stocks

June 04, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Solventum (NYSE:SOLV) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

3 Healthcare Stocks Skating on Thin Ice

June 02, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

2 Profitable Stocks Worth Investigating and 1 to Be Wary Of

May 26, 2025

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way

May 19, 2025

Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Assessing Solventum: Insights From 9 Financial Analysts ↗

May 19, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Solventum Corporation Common Stock (NY:SOLV)

All News about Solventum Corporation Common Stock

Starting at $3.75/week.

Subscribe Today